CR:DOI:fa5a924ce400bc9f7a71b219c95b68c2
From IDWiki
{{#scite:
|reference=ng2018lo
|type=article-journal
|title=Low Frequency of Opportunistic Infections in Patients Receiving Vedolizumab in Clinical Trials and Post-Marketing Setting
|author=Siew C Ng;Ida Normiha Hilmi;Aimee Blake;Fatima Bhayat;Shashi Adsul;Qasim Rana Khan;Deng-Chyang Wu|+sep=;
|journal=Inflammatory Bowel Diseases
|publisher=Oxford University Press (OUP)
|year=2018
|volume=24
|issue=11
|pages=2431-2441
|doi=10.1093/ibd/izy153
|subject=Immunology and Allergy;Gastroenterology|+sep=;
|issn=1078-0998;1536-4844|+sep=;
|retrieved-from=https://dx.doi.org/
|retrieved-on=2019-11-05
}}
